Alnylam Pharmaceuticals (ALNY) Stock Chart & Stock Price History → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ALNY Stock Alerts $146.93 +1.14 (+0.78%) (As of 11:56 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Alnylam Pharmaceuticals Stock Price Performance5 Day Performance+1.22%1 Month Performance+0.29%3 Month Performance-22.55%6 Month Performance-9.30%Year-To-Date Performance-23.24%1 Year Performance-29.79% Receive ALNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him ALNY Stock Chart for Tuesday, April, 23, 2024 ALNY Chart by TradingView Alnylam Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$144.41$145.79+0.96%$147.86$143.69399,984 shs$18.36 billion04/19/2024$145.16$144.41-0.52%$146.92$143.51703,168 shs$18.19 billion04/18/2024$145.32$145.16-0.11%$146.45$144.50398,901 shs$18.28 billion04/17/2024$146.72$145.32-0.95%$147.49$145.19601,282 shs$18.30 billion04/16/2024$147.70$146.72-0.66%$148.44$146.01352,424 shs$18.48 billion04/15/2024$148.50$147.70-0.54%$150.37$146.73498,935 shs$18.60 billion Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$152.09$148.50-2.36%$151.80$148.28427,819 shs$18.70 billion04/11/2024$152.41$152.09-0.21%$154.02$149.93473,409 shs$19.16 billion04/10/2024$155.90$152.41-2.24%$154.96$151.91571,298 shs$19.20 billion04/09/2024$156.04$155.90-0.09%$159.34$154.89595,956 shs$19.64 billion04/08/2024$153.56$156.04+1.62%$157.96$153.25738,213 shs$19.65 billion04/05/2024$151.48$153.56+1.37%$154.00$149.41351,489 shs$19.34 billion04/04/2024$150.83$151.48+0.43%$154.34$150.81531,882 shs$19.08 billion04/03/2024$151.04$150.83-0.14%$151.27$149.25315,048 shs$19.00 billion04/02/2024$153.33$151.04-1.49%$152.27$150.67445,640 shs$19.02 billion04/01/2024$149.45$153.33+2.60%$154.20$147.58523,250 shs$19.31 billion03/29/2024$149.45$149.45$154.50$149.32666,592 shs$18.82 billion03/28/2024$154.39$149.45-3.20%$154.50$149.32666,576 shs$18.82 billion03/27/2024$151.97$154.39+1.59%$155.28$150.40463,043 shs$19.45 billion03/26/2024$152.07$151.97-0.07%$153.43$150.81532,230 shs$19.14 billion03/25/2024$146.51$152.07+3.79%$152.63$147.13799,298 shs$19.15 billion03/22/2024$146.62$146.51-0.08%$147.10$143.66834,175 shs$18.45 billion03/21/2024$147.99$146.62-0.93%$150.68$145.41611,511 shs$18.47 billion03/20/2024$148.17$147.99-0.12%$148.64$145.22439,772 shs$18.64 billion03/19/2024$147.41$148.17+0.52%$149.69$146.00517,163 shs$18.66 billion03/18/2024$149.27$147.41-1.25%$151.00$147.22460,718 shs$18.57 billion03/15/2024$148.53$149.27+0.50%$150.09$145.54905,205 shs$18.80 billion03/14/2024$148.42$148.53+0.07%$149.59$145.77505,840 shs$18.71 billion03/13/2024$146.65$148.42+1.21%$151.46$146.82858,993 shs$18.69 billion03/12/2024$149.10$146.65-1.64%$150.02$146.61683,429 shs$18.47 billion03/11/2024$149.82$149.10-0.48%$152.50$148.88661,992 shs$18.78 billion03/08/2024$149.86$149.82-0.03%$152.88$149.14637,629 shs$18.87 billion03/07/2024$149.66$149.86+0.13%$150.56$149.24563,928 shs$18.87 billion03/06/2024$149.68$149.66-0.01%$150.24$147.63521,529 shs$18.85 billion03/05/2024$150.04$149.68-0.24%$151.21$147.52620,483 shs$18.85 billion03/04/2024$152.61$150.04-1.68%$154.85$149.89950,685 shs$18.90 billion03/01/2024$151.09$152.61+1.01%$155.91$150.00523,455 shs$19.22 billion02/29/2024$155.23$151.09-2.67%$157.52$149.001.81 million shs$19.03 billion02/28/2024$159.00$155.23-2.37%$158.90$153.941.26 million shs$19.55 billion02/27/2024$158.66$159.00+0.21%$161.31$157.91674,827 shs$20.03 billionThis Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry02/26/2024$157.65$158.66+0.64%$159.04$153.94556,235 shs$19.98 billion02/23/2024$162.81$157.65-3.17%$163.01$155.821.48 million shs$19.86 billion02/22/2024$154.74$162.81+5.22%$164.02$154.031.17 million shs$20.51 billion02/21/2024$149.69$154.74+3.37%$155.38$148.843.66 million shs$19.49 billion02/20/2024$147.00$149.69+1.83%$150.06$145.811.29 million shs$18.85 billion02/19/2024$147.00$147.00$150.93$146.821.89 million shs$18.51 billion02/16/2024$147.43$147.00-0.29%$150.93$146.821.89 million shs$18.45 billion02/15/2024$164.15$147.43-10.19%$153.27$143.525.43 million shs$18.50 billion02/14/2024$162.00$164.15+1.33%$164.63$161.51931,439 shs$20.60 billion02/13/2024$169.34$162.00-4.33%$166.50$160.84800,278 shs$20.33 billion02/12/2024$170.03$169.34-0.41%$171.57$166.87782,411 shs$21.25 billion02/09/2024$169.50$170.03+0.31%$171.86$168.54481,037 shs$21.34 billion02/08/2024$168.60$169.50+0.53%$170.25$165.591.61 million shs$21.27 billion02/07/2024$172.18$168.60-2.08%$172.55$167.43771,746 shs$21.16 billion02/06/2024$170.70$172.18+0.87%$173.18$169.811.44 million shs$21.61 billion02/05/2024$173.06$170.70-1.36%$172.73$168.00602,382 shs$21.42 billion02/02/2024$174.92$173.06-1.06%$174.48$169.32639,127 shs$21.72 billion02/01/2024$172.91$174.92+1.16%$176.35$172.21624,761 shs$21.95 billion01/31/2024$180.12$172.91-4.00%$179.80$172.37836,469 shs$21.70 billion01/30/2024$180.96$180.12-0.46%$181.66$178.36475,718 shs$22.60 billion01/29/2024$179.62$180.96+0.75%$181.50$176.121.04 million shs$22.71 billion01/26/2024$183.93$179.62-2.34%$184.29$179.47517,399 shs$22.54 billion01/25/2024$185.20$183.93-0.69%$188.69$183.03533,776 shs$23.08 billion01/24/2024$189.70$185.20-2.37%$191.72$185.13531,326 shs$23.24 billion01/23/2024$183.92$189.70+3.14%$190.37$183.45645,346 shs$23.81 billion01/22/2024$184.03$183.92-0.06%$189.98$182.60577,174 shs$23.08 billion Related Companies: BioMarin Pharmaceutical Stock Price Chart Royalty Pharma Stock Price Chart United Therapeutics Stock Price Chart Ionis Pharmaceuticals Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Genmab A/S Stock Price Chart Teva Pharmaceutical Industries Stock Price Chart Viatris Stock Price Chart BeiGene Stock Price Chart Karuna Therapeutics Stock Price Chart Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALNY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.